[1]
|
Cancer Genome Atlas Network.Comprehensive molecular portraits of human breast tumours[J].Nature, 2012, 490(7418):61. doi: 10.1038/nature11412 |
[2]
|
MONTAGNA E.Heterogeneity of triple-negative breast cancer:histologic subtyping to inform the outcome[J].Clin Breast Cancer, 2013, 13(1):31. |
[3]
|
GUCALP A, TRAINA TA.Triple-negative breast cancer:adjuvant therapeutic options[J].Chemother Res Pract, 2011, 2011:696208. |
[4]
|
Franco-Chuaire ML, Magda Carolina SC, Chuaire-Noack L.Epithelial-mesenchymal transition (EMT); principles and clinical impact in cancer therapy[J].Invest Clin, 2013.54(2):186. |
[5]
|
LIANG O, LAN Z, FU L, et al.A small-molecule activator induces ULK1-modulating autophagy-associated cell death in triple negative breast cancer[J].Autophagy, 2017, 13(4):777. doi: 10.1080/15548627.2017.1283470 |
[6]
|
BRAICU C, PILECZKI V, POP L, et al.Dual targeted therapy with p53 siRNA and Epigallocatechingallate in a triple negative breast cancer cell model[J].Plos One, 2015, 10(4):e0120936. doi: 10.1371/journal.pone.0120936 |
[7]
|
CHANG CT, HSEU YC, THIYAGARAJAN V, et al.Antrodia salmonea, induces G 2, cell-cycle arrest in human triple-negative breast cancer (MDA-MB-231) cells and suppresses tumor growth in athymic nude mice[J].J Ethnopharmacol, 2017, 196:9. doi: 10.1016/j.jep.2016.12.018 |
[8]
|
GARBAR C, MASCAUX C, GIUSTINIANI J, et al.Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231[J].Sci Rep, 2017, 7(1):7201. |
[9]
|
LIU Z, HE K, MA Q, et al.Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer[J].Plos One, 2017, 12(5):e0177694. doi: 10.1371/journal.pone.0177694 |
[10]
|
KOH DW, POWELL DP, BLAKE SD, et al.Enhanced cytotoxicity in triple-negative and estrogen receptor-positive breast adenocarcinoma cells due to inhibition of the transient receptor potential melastatin-2 channel[J].Oncol Rep, 2015, 34(3):1589. |
[11]
|
FAN YX, DAI YZ, WANG XL, et al.MiR-18a upregulation enhances autophagy in triple negative cancer cells via inhibiting mTOR signaling pathway[J].Eur Rev Med Pharmacol Sci, 2016, 20(11):2194. |
[12]
|
BERRADA NS, ANDRE DF.Treatment of triple-negative metastatic breast cancer:toward individualized targeted treatments or chemosensitization?[J].Ann Oncol, 2010, 21(Suppl 7):vii30. |
[13]
|
WANG C, MAO C, LOU Y, et al.Monotropein promotes angiogenesis and inhibits oxidative stress-induced autophagy in endothelial progenitor cells to accelerate wound healing[J].J Cell Mol Med, 2017, 22(3):1583. |
[14]
|
HAMACHER-BRADY A, BRADY NR.Mitophagy programs:mechanisms and physiological implications of mitochondrial targeting by autophagy[J].Cell Mol Life Sci, 2015, 73(4):775. |
[15]
|
DAS CK, LINDER B, BONN F, et al.BAG3 overexpression and cytoprotective autophagy mediate apoptosis resistance in chemoresistant breast cancer cells[J].Neoplasia, 2018, 20(3):263. doi: 10.1016/j.neo.2018.01.001 |
[16]
|
HAMURCU Z, DELIBAŞI N, GEÇENE S, et al.Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/Src signaling in triple negative breast cancer cells[J].J Cancer Res Clin Oncol, 2018, 144(3):415. doi: 10.1007/s00432-017-2557-5 |
[17]
|
WANG MC, WU AG, HUANG YZ, et al.Autophagic regulation of cell growth by altered expression of Beclin 1 in triple-negative breast cancer[J].Int J Clin Exp Med, 2014, 8(5):7049. |